These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20220352)

  • 1. Athletes, NSAID, coxibs, and the gastrointestinal tract.
    Lilly KF
    Curr Sports Med Rep; 2010; 9(2):103-5. PubMed ID: 20220352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.
    Hur C; Chan AT; Tramontano AC; Gazelle GS
    Ann Pharmacother; 2006 Jun; 40(6):1052-63. PubMed ID: 16720709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.
    Tannenbaum H; Bombardier C; Davis P; Russell AS;
    J Rheumatol; 2006 Jan; 33(1):140-57. PubMed ID: 16331802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quo vadetis coxibs?].
    Grazio S; Anić B
    Reumatizam; 2005; 52(1):17-27. PubMed ID: 16689107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract.
    Sostres C; Gargallo CJ; Arroyo MT; Lanas A
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):121-32. PubMed ID: 20227026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
    Coruzzi G; Venturi N; Spaggiari S
    Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
    LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
    Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-associated hyponatremia, renal function, and nonsteroidal antiinflammatory drug use in an ultraendurance mountain run.
    Page AJ; Reid SA; Speedy DB; Mulligan GP; Thompson J
    Clin J Sport Med; 2007 Jan; 17(1):43-8. PubMed ID: 17304005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetaminophen or NSAIDs for the treatment of osteoarthritis.
    Bannwarth B
    Best Pract Res Clin Rheumatol; 2006 Feb; 20(1):117-29. PubMed ID: 16483911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L; Hritz I; Molnar B; Herszenyi L; Tulassay Z
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):23-30. PubMed ID: 14552701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease.
    Whelton A
    Am J Cardiol; 2006 May; 97(9A):3-9. PubMed ID: 16675316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM
    Gastroenterol Clin North Am; 2009 Jun; 38(2):305-14. PubMed ID: 19446260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
    Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
    Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R; Rubin G; Berenbaum F; Scheiman J
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for pain.
    Treat Guidel Med Lett; 2010 Apr; 8(92):25-34. PubMed ID: 20339342
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use.
    Paoloni JA; Milne C; Orchard J; Hamilton B
    Br J Sports Med; 2009 Oct; 43(11):863-5. PubMed ID: 19546098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS; Abdul-Hadi O; Parvizi J; Viscusi ER; Einhorn T
    Instr Course Lect; 2009; 58():759-68. PubMed ID: 19385584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.